Botulinum toxin therapy in Frey's syndrome: a retrospective study of 440 treatments in 100 patients
- 29 August 2016
- journal article
- Published by Wiley in Clinical Otolaryngology
- Vol. 42 (2), 295-300
- https://doi.org/10.1111/coa.12719
Abstract
Frey's syndrome is characterized as sweating, redness and warmth of the parotideal area and is often treated with botulinum toxin A. The objective of this retrospective study was to prove, whether the toxin dosage and time-to-treatment intervals change after repeated botulinum toxin injections. The charts of patients, who were treated for Frey′s syndrome during the last 16 years, were assessed. Three brands of botulinum toxin A were available for therapy. The Minor test was used to confirm the sweating before each treatment and to determine the toxin dosage. Constant amount of botulinum toxin was injected per cm2 of the affected area. Patients consulted our department for the next treatment as soon as they felt disturbed by recurring sweating and when the sweating was objectively evident in the Minor test. Time intervals between treatments and injected toxin dosages were assessed. In total, 100 patients received 440 treatments in 16 years. Repeated injections, median 4.0, were carried out in 70.5% of patients. Median time interval to the first injection was 2.8 years. Median time interval between treatments was 12.0 months and showed to be steady (ANOVA, p=.49, F=1.01). Duration of effect of botulinum toxin on Frey's syndrome was long lasting and stable with no significantly different time intervals between treatments. The extent of the sweating area did not vary significantly after repeated treatments and required a constant dose of botulinum toxin A.Keywords
This publication has 25 references indexed in Scilit:
- Sternocleidomastoid muscle flap in preventing Frey's syndrome after parotidectomy: A systematic reviewHead & Neck, 2011
- Safety and Efficacy of Botulinum Toxin Therapy in Otorhinolaryngology: Experience From 1,000 TreatmentsThe Laryngoscope, 2008
- The use of botulinum toxin in head and face medicine: An interdisciplinary fieldHead & Face Medicine, 2008
- Risk of facial palsy and severe Frey's syndrome after conservative parotidectomy for benign disease: analysis of 610 operationsActa Oto-Laryngologica, 2006
- Botulinum toxin A in the treatment of patients with Frey syndromeBritish Journal of Surgery, 2002
- Botulinum Toxin: Basic Science and Clinical Uses in OtolaryngologyThe Laryngoscope, 2001
- Treatment of gustatory sweating with botulinum toxinAnnals of Neurology, 1997
- Frey's Syndrome: Treatment with Botulinum ToxinActa Oto-Laryngologica, 1995
- Mechanism of action of tetanus and botulinum neurotoxinsMolecular Microbiology, 1994
- Das gustatorische Schwitzen nach ParotidektomieLaryngo-Rhino-Otologie, 1986